Internal Medicine, Pulmonary Disease · Albuquerque, NM
NPI
1891889283
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1101 Medical Arts Ave NE, Pmg Southwest Pulmonary Critical Care
Albuquerque, NM, 87102
Phone (505) 842-5105
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
1,164 services
Medicare patients, 2024
564
Average age 74
Drug cost, 2024
$2.2M
4,174 prescriptions
Company payments, 2025
$39.06
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Archie J Sanchez was code 99214 (office e&m - established), 393 times for 277 patients. In total Archie J Sanchez billed 1,164 services in 11 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 393 | 277 | $65.99 | $26K |
| 94726 Pulmonary Function Testing | Office | 154 | 150 | $8.40 | $1,293 |
| 94729 Pulmonary Function Testing | Office | 149 | 147 | $6.35 | $946 |
| 94010 Pulmonary Function Testing | Office | 124 | 118 | $5.64 | $700 |
| 94060 Pulmonary Function Testing | Office | 116 | 112 | $7.28 | $844 |
| 99204 Office E&M - New | Office | 66 | 66 | $85.07 | $5,615 |
| 99215 Office E&M - Established | Office | 52 | 38 | $97.17 | $5,053 |
| 94729 Pulmonary Function Testing | Facility | 26 | 26 | $6.70 | $174 |
| 94726 Pulmonary Function Testing | Facility | 25 | 25 | $9.01 | $225 |
| 94060 Pulmonary Function Testing | Facility | 19 | 19 | $6.09 | $116 |
| 94010 Pulmonary Function Testing | Facility | 17 | 17 | $5.82 | $98.96 |
| 99213 Office E&M - Established | Office | 12 | 12 | $39.64 | $476 |
By year: 2022 $45K for 1,094 services; 2023 $44K for 1,066 services; 2024 $42K for 1,164 services.
Medicare prescription drug claims, 2024
In 2024, the drug Archie J Sanchez prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 706 prescriptions and refills. In total Archie J Sanchez wrote 4,174 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 706 | 778 | 115 | $495K |
| Symbicort Budesonide/Formoterol Fumarate | 559 | 743 | 119 | $170K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 542 | 667 | 195 | $21K |
| Spiriva Respimat Tiotropium Bromide | 328 | 404 | 55 | $203K |
| Prednisone Generic | 212 | 237 | 93 | $1,754 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 176 | 254 | 38 | $26K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 146 | 196 | 29 | $91K |
| Breo Ellipta Fluticasone/Vilanterol | 137 | 160 | 26 | $60K |
| Azithromycin Generic | 122 | 144 | 36 | $1,830 |
| Arnuity Ellipta Fluticasone Furoate | 121 | 139 | 23 | $35K |
| Montelukast Sodium Generic | 106 | 298 | 37 | $1,727 |
| Ventolin Hfa Albuterol Sulfate | 104 | 129 | 26 | $9,404 |
| Spiriva Handihaler Tiotropium Bromide | 90 | 134 | 16 | $65K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 68 | 103 | 18 | $11K |
| Fluticasone Propionate Hfa Fluticasone Propionate | 56 | 98 | 17 | $11K |
Brand drugs: 2,926 claims; generic drugs: 1,248 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Archie J Sanchez $39.06 ($39.06 in general payments such as food, travel and fees) from 1 company. The largest payer was Insmed, Inc. with $39.06.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 2 | $39.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.